A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and vendors on messaging platforms, according to new investigations.
Experimental Treatment Gaining Popularity Via Social Media
Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a robust trade exists on messaging services, where communities with thousands of members share comparison images, administration instructions and assertions of next-day British shipping. Sellers promote the substance there before redirecting customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could assist individuals lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Medical Professionals Express Concerns
However, doctors and chemists have cautions that the distribution of what remains an unapproved medication in the UK is worrisome and could lead to users administering substances of unknown origin.
Some professionals said the popularity for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on TikTok or Telegram is prohibited in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.
Some content creators attempt to circumvent the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach medicines, advertising, and customer regulations, potentially leading to fines, legal action or prison.
Platform Reaction and Content Elimination
According to TikTok, the platform has taken down problematic content and prohibited associated keywords and query recommendations. The company stated it was dedicated to keeping the platform secure and investing in strengthening compliance measures.
Digital Marketplace Operations
Research also found groups with up to nine thousand participants marketing retatrutide using the platform's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of users, populated with images of weight loss, positive testimonials and detailed guides for mixing or injecting at home.
After moments of entering one community, a seller posted contact information, where the majority of purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about weight, medical conditions or previous experience.
Item Information and Costs
Inside these groups, messages display dark colored parcels with postal service labels, claiming to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens usually priced at 160 pounds for 20 milligrams. When asked how much time a pen should be used, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Actions
A representative for Telegram said it regularly monitored harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are injecting materials they cannot confirm. Even if the science behind this drug is sound, these online products may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are turning to online platforms. But counterfeit treatments are extremely risky. You cannot know what’s contained or whether the environment they were made in was clean,” she said.
Her team has already encountered individuals injured by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority globally. “Consequently at this point no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a Lilly experimental product not yet approved … may subject patients to possibly serious medical dangers”.
